Literature DB >> 8198450

Inactivation of human cytomegalovirus by sodium periodate oxidation.

F Geoffroy1, G Ogier, J Chantepie, G Quash.   

Abstract

Human cytomegalovirus (HCMV), oxidized by sodium periodate (NaIO4), is incapable of giving rise to viral progeny in cell culture. At a NaIO4 concentration as low as 5 mM, there is a loss of at least 6 logs of viral infectivity which occurs very rapidly (less than 5 min). Further, the inactivation is a first-order reaction depending on the periodate concentration. Adsorption to the cell surface, penetration into cells, and penetration of the viral DNA into cell nuclei were found to occur identically in mock oxidized and oxidized HCMV. Since the carbohydrate moiety of viral glycoproteins was the target of periodate attack, these observations strongly suggest that the structural integrity of the sugar residues is not a prerequisite for adsorption and penetration. Nevertheless, no evidence for viral DNA or protein synthesis was detected in cells infected with oxidized virus, and even after 3 weeks in culture, no cytopathic effect was observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198450     DOI: 10.1007/bf01309765

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  30 in total

Review 1.  Human cytomegalovirus: biology and clinical perspectives.

Authors:  R C Gehrz
Journal:  Adv Pediatr       Date:  1991

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Enzymic assay for spermine and spermidine.

Authors:  U Bachrach; B Reches
Journal:  Anal Biochem       Date:  1966-10       Impact factor: 3.365

Review 4.  Management of cytomegalovirus disease with antiviral drugs.

Authors:  H H Balfour
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

Review 5.  Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.

Authors:  D R Snydman
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

6.  Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease.

Authors:  A Porath; R A McNutt; L M Smiley; K A Weigle
Journal:  Rev Infect Dis       Date:  1990 Jan-Feb

Review 7.  Treatment of cytomegalovirus disease.

Authors:  D Emanuel
Journal:  Semin Hematol       Date:  1990-04       Impact factor: 3.851

8.  Expression of a human cytomegalovirus receptor correlates with infectibility of cells.

Authors:  D M Nowlin; N R Cooper; T Compton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

9.  A general method for preparing chromatin containing intact DNA.

Authors:  D A Jackson; P R Cook
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

Review 10.  Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.

Authors:  H G Bahnemann
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

View more
  1 in total

1.  Inhibition of type 5 adenovirus infectivity by periodate oxidation.

Authors:  G Ogier; Y Michal; V Thomas; G Quash; J D Rodwell
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.